<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Cancer Causes Control</journal-id><journal-id journal-id-type="iso-abbrev">Cancer Causes Control</journal-id><journal-title-group><journal-title>Cancer Causes &#x00026; Control</journal-title></journal-title-group><issn pub-type="ppub">0957-5243</issn><issn pub-type="epub">1573-7225</issn><publisher><publisher-name>Springer International Publishing</publisher-name><publisher-loc>Cham</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39779648</article-id><article-id pub-id-type="pmc">PMC12098401</article-id>
<article-id pub-id-type="publisher-id">1949</article-id><article-id pub-id-type="doi">10.1007/s10552-024-01949-2</article-id><article-categories><subj-group subj-group-type="heading"><subject>Brief Report</subject></subj-group></article-categories><title-group><article-title>Impact of declared wildfire disasters on survival of lung cancer patients undergoing radiation</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Lichter</surname><given-names>Katie E.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><name><surname>Larson</surname><given-names>Bria</given-names></name><address><email>brialarson@berkeley.edu</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Pagadala</surname><given-names>Meghana</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Mohamad</surname><given-names>Osama</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Nogueira</surname><given-names>Leticia</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/043mz5j54</institution-id><institution-id institution-id-type="GRID">grid.266102.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2297 6811</institution-id><institution>Department of Radiation Oncology, </institution><institution>University of California San Francisco, </institution></institution-wrap>San Francisco, CA USA </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01an7q238</institution-id><institution-id institution-id-type="GRID">grid.47840.3f</institution-id><institution-id institution-id-type="ISNI">0000 0001 2181 7878</institution-id><institution>School of Public Health, </institution><institution>University of California Berkeley, </institution></institution-wrap>Berkeley, CA USA </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02yrq0923</institution-id><institution-id institution-id-type="GRID">grid.51462.34</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 9952</institution-id><institution>Department of Medicine, </institution><institution>Memorial Sloan Kettering Cancer Center, </institution></institution-wrap>New York, USA </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04twxam07</institution-id><institution-id institution-id-type="GRID">grid.240145.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2291 4776</institution-id><institution>Department of Radiation Oncology, </institution><institution>MD Anderson, </institution></institution-wrap>Houston, TX USA </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02e463172</institution-id><institution-id institution-id-type="GRID">grid.422418.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 0371 6485</institution-id><institution>Surveillance and Health Equity Science, </institution><institution>American Cancer Society, </institution></institution-wrap>Kennesaw, GA USA </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/043mz5j54</institution-id><institution-id institution-id-type="GRID">grid.266102.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2297 6811</institution-id><institution>Helen Diller Family Comprehensive Cancer Center, </institution><institution>University of California San Francisco, </institution></institution-wrap>San Francisco, CA USA </aff></contrib-group><pub-date pub-type="epub"><day>9</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>9</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>36</volume><issue>6</issue><fpage>561</fpage><lpage>565</lpage><history><date date-type="received"><day>29</day><month>10</month><year>2024</year></date><date date-type="accepted"><day>17</day><month>12</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><sec><title>Purpose</title><p id="Par1">Oncological treatments, such as radiotherapy, which requires consistent electricity, the presence of specialized clinical teams, and daily patient access to treatment facilities, are frequently disrupted by extreme weather events, posing several health hazards to patients. This study explores the association between declared wildfire disasters during radiotherapy and overall survival among patients with non-small cell lung cancer (NSCLC).</p></sec><sec><title>Methods</title><p id="Par2">The study population consisted of 202,935 adults with inoperable Stage III NSCLC, who initiated radiotherapy from 2004 through 2019. Exposure was defined as a wildfire disaster declaration in the county of the treatment facility within 12&#x000a0;weeks of initiating radiotherapy. Overall survival was defined as the interval (months) between age at diagnosis and age at death, date of last contact, or study end. Cox proportional hazards was used to estimate crude and adjusted hazard ratios and 95% confidence intervals with inverse probability weighting.</p></sec><sec><title>Results</title><p id="Par3">Patients exposed to a wildfire disaster declaration during radiation treatment had worse overall survival (HR, 1.03; 95% CI 1.00&#x02013;1.06; <italic>p</italic>&#x02009;=&#x02009;0.02), compared to unexposed patients in adjusted models.</p></sec><sec><title>Conclusion</title><p id="Par4">Exposure to a wildfire disaster during radiotherapy is associated with worse overall survival among patients with stage III non-operable NSCLC. This finding underscores the critical need for developing adaptation strategies within the healthcare sector, especially in oncology.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Wildfires</kwd><kwd>Radiotherapy</kwd><kwd>Oncology</kwd><kwd>Lung cancer</kwd><kwd>Disasters</kwd><kwd>Survival</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Nature Switzerland AG 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par5">Climate change is one of the strongest factors contributing to increasing wildfire activity in the US [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR3">3</xref>]. Climate-driven disasters, such as wildfires, can damage medical infrastructure (e.g., facilities, equipment), compromise transportation routes, interrupt supply chains, and frequently result in disruptions in access to cancer care [<xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par6">Oncological treatments such as radiotherapy, which requires consistent electricity, daily patient access to the treating facility, and the presence of specialized teams, are particularly vulnerable to disruptions caused by climate-driven extreme weather events [<xref ref-type="bibr" rid="CR5">5</xref>]. One previous study found 100% of radiation oncology clinics in California were within 25 miles of a wildfire between 2017 and 2022, most of which (61%) experienced disruptions in services including canceling scheduled treatments [<xref ref-type="bibr" rid="CR6">6</xref>].</p><p id="Par7">Disruptions in access to radiation treatment are especially concerning for patients diagnosed with aggressive tumors, such as locally advanced non-small cell lung cancer (NSCLC) [<xref ref-type="bibr" rid="CR7">7</xref>], for whom daily radiation treatment over several weeks is critical to achieving optimal outcomes [<xref ref-type="bibr" rid="CR8">8</xref>]. Importantly, NSCLC remains the leading cause of cancer-related deaths worldwide [<xref ref-type="bibr" rid="CR9">9</xref>], with an overall 5-year survival rate of 25% despite advances in therapy [<xref ref-type="bibr" rid="CR10">10</xref>]. For early-stage disease, surgery is usually curative, while a combination of chemotherapy and radiation therapy, and more recently immunotherapy, are the recommended treatment strategies for advanced disease [<xref ref-type="bibr" rid="CR11">11</xref>]. Risk factors for mortality include older age, comorbidities, and more advanced disease [<xref ref-type="bibr" rid="CR11">11</xref>]. Further, even minor delays in radiation therapy&#x02014;such as a treatment completion time prolonged by just 2&#x000a0;days&#x02014;are associated with reduced overall survival [<xref ref-type="bibr" rid="CR12">12</xref>&#x02013;<xref ref-type="bibr" rid="CR15">15</xref>].</p><p id="Par8">Previous research found that exposure to hurricane disasters during radiotherapy was associated with worse survival among patients with NSCLC [<xref ref-type="bibr" rid="CR16">16</xref>]. However, the impact of climate-driven disasters on cancer outcomes remains largely unrecognized and unaddressed, and there are still no guidelines for addressing the detrimental health consequences associated with exposure to disasters during cancer treatment [<xref ref-type="bibr" rid="CR17">17</xref>]. Better characterizing the association between exposure to climate-driven disasters and mortality is fundamental for informing future research efforts aimed at developing disaster preparedness and response strategies aimed at better protecting the health and safety of patients undergoing cancer treatment in the era of climate change. Therefore, this study builds on prior research and explores the association between declared wildfire disasters during radiotherapy and overall survival among patients diagnosed with inoperable locally advanced NSCLC.</p></sec><sec id="Sec2"><title>Methods</title><p id="Par9">Individuals aged 18&#x000a0;years and older diagnosed with Stage III NSCLC, who did not receive surgical treatment and initiated definitive radiotherapy from 2004 to 2019 were identified in the National Cancer Database (NCDB), a hospital-based cancer registry co-sponsored by the American College of Surgeons and the American Cancer Society. [<xref ref-type="bibr" rid="CR18">18</xref>] The NCDB follows the North America Association of Central Cancer Registries (NAACCR) guidelines for cancer data abstraction and processing, which ensures uniform registry processes and ensures data quality standards [<xref ref-type="bibr" rid="CR19">19</xref>]. Therefore, cases were selected using established ICD-O-3 topology and histology codes for NSCLC [<xref ref-type="bibr" rid="CR20">20</xref>]. Exposure was defined as a Federal Emergency Management Agency (FEMA) wildfire disaster declaration in the county of the treatment facility within 12&#x000a0;weeks of initiating radiotherapy, as this period reflects the typical duration of treatment for locally advanced NSCLC, including potential delays or interruptions [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. Time-varying inverse probability weights were generated using logistic regression including geographic region, age, sex, chemotherapy initiation, and month of follow-up to correct for immortal time bias because exposed patients had guaranteed survival between date when radiotherapy started and date of exposure [<xref ref-type="bibr" rid="CR22">22</xref>]. Geographic region was categorized into Northeast (CT, MA, ME, NH, NJ, NY, PA, RI, VT), Midwest (IA, IL, IN, KS, MN, MO, MI, NE, ND, OH, SD, WI), South (AL, AR, DE, DC, FL, GA, LA, KY, MD, MS, NC, SC, OK, TN, TX, VA, WV), West (AZ, CA, CO, ID, MT, NM, NV, OR, UT, WA, WY) following the US Census Bureau definition [<xref ref-type="bibr" rid="CR23">23</xref>]. Patients exposed to coastal storm, flood, hurricane, severe ice storm, severe storm, snowstorm, tornado, tropical depression, tropical storm, and winter storm disasters were censored at the date when the disaster was declared.</p><p id="Par10">Overall survival was defined as the interval (months) between age at diagnosis and age at death, last known contact, or study end (December 31, 2019), whichever occurred first. A Cox proportional hazards model was used to estimate crude and adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) with inverse probability weighting. Adjusted models included sex, geographic region, health insurance type, comorbidities defined using the modified Charlson and Deyo comorbidity index for cancer patients (categorized into 0, 1, or&#x02009;&#x02265;&#x02009;2) [<xref ref-type="bibr" rid="CR24">24</xref>], lymph node involvement, type of facility, and concomitant chemotherapy. These variables were selected as potential confounders for the association of exposure to wildfire disaster during radiotherapy and cancer outcomes using qualitative a priori subject matter knowledge [<xref ref-type="bibr" rid="CR25">25</xref>].</p><p id="Par11">Descriptive statistics included self-identified race and ethnicity to show the diversity of the study population. We chose not to include race and ethnicity in the adjusted models to avoid incorrectly assigning race (a social construct that should only be used as a proxy for exposure to racism) as a risk factor [<xref ref-type="bibr" rid="CR26">26</xref>].</p><p id="Par12">The institutional review board of the Morehouse School of Medicine granted an exemption for this study in accordance with 45 CFR &#x000a7;46.102(f).</p></sec><sec id="Sec3"><title>Results</title><p id="Par13">Of a total of 202,935 individuals included in the study, 1,513 (0.75%) were exposed to a wildfire disaster within 12&#x000a0;weeks of radiation treatment start date. Mean age at radiotherapy start date was 67.9&#x000a0;years and the majority of patients were male (54.6%). Exposure to a wildfire disaster during radiotherapy was most common among patients residing in the West region (73.4%), followed by the South (25.8%). No patients were exposed to&#x02009;&#x0003e;&#x02009;1 wildfire disaster within 12&#x000a0;weeks of initiating treatment. The median follow-up was 14&#x000a0;months. In the exposed group, the total number of deaths was 1,248 and mean survival time was 24.8&#x000a0;months. In the unexposed group, the total number of deaths was 162,366 and mean survival time was 23.8&#x000a0;months. Although the association was not significant in crude models (HR 0.98; 95% CI 0.96&#x02013;10.3; <italic>p</italic>&#x02009;=&#x02009;0.08), patients exposed to a wildfire disaster declaration during radiation treatment had worse overall survival (HR, 1.03; 95% CI 1.00&#x02013;1.06; <italic>p</italic>&#x02009;=&#x02009;0.02) than unexposed patients in adjusted models.</p></sec><sec id="Sec4"><title>Discussion</title><p id="Par14">Exposure to a wildfire disaster during radiotherapy is associated with worse overall survival among patients diagnosed with stage III non-operable NSCLC. The results of the present study align with the previous study reporting worse overall survival among patients undergoing radiotherapy for non-operable locally-advanced NSCLC [<xref ref-type="bibr" rid="CR16">16</xref>]. Hurricane disasters potentially result in more dramatic disruptions in radiotherapy care, as previously reported [<xref ref-type="bibr" rid="CR27">27</xref>], while wildfires are potentially more common, especially in the West region of the US [<xref ref-type="bibr" rid="CR6">6</xref>]. Moreover, the dynamic and frequently compounding hazards posed by wildfires, including air contaminated with smoke, water and soil contamination with byproducts of burned vegetation and human-made products, and the cognitive and physical challenges of following evacuation orders [<xref ref-type="bibr" rid="CR28">28</xref>], interact with the physical and psychological challenges experienced by patients diagnosed with NSCLC [<xref ref-type="bibr" rid="CR22">22</xref>], potentially increasing vulnerability to wildfire disasters hazards in this population (Tables <xref rid="Tab1" ref-type="table">1</xref> and <xref rid="Tab2" ref-type="table">2</xref>).<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Demographic and clinical characteristics of patients with stage III non-operable NSCLC undergoing radiotherapy 2004&#x02013;2019</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="2"/><th align="left">Overall</th><th align="left">Exposed</th><th align="left">Unexposed</th></tr></thead><tbody><tr><td align="left" colspan="2"><italic>n</italic></td><td align="left">202,935</td><td align="left">1513</td><td align="left">201,422</td></tr><tr><td align="left" colspan="2">Age at radiotherapy start date, mean (SD)</td><td align="left">67.9 (10.3)</td><td align="left">68.5 (10.7)</td><td align="left">67.8 (10.3)</td></tr><tr><td align="left">Sex, <italic>n</italic> (%)</td><td align="left">Male</td><td align="left">110,724 (54.6)</td><td align="left">790 (52.2)</td><td align="left">109,934 (54.6)</td></tr><tr><td align="left"/><td align="left">Female</td><td align="left">92,171 (45.4)</td><td align="left">722 (47.8)</td><td align="left">91,449 (45.4)</td></tr><tr><td align="left">Race/ethnicity, <italic>n</italic> (%)</td><td align="left">Non-Hispanic White</td><td align="left">167,868 (83.2)</td><td align="left">1165 (77.2)</td><td align="left">166,703 (83.2)</td></tr><tr><td align="left"/><td align="left">Hispanic</td><td align="left">4502 (2.2)</td><td align="left">120 (7.9)</td><td align="left">4382 (2.2)</td></tr><tr><td align="left"/><td align="left">Non-Hispanic Black</td><td align="left">24,996 (12.4)</td><td align="left">111 (7.4)</td><td align="left">24,885 (12.4)</td></tr><tr><td align="left"/><td align="left">Asian &#x00026; Pacific Islander</td><td align="left">3275 (1.6)</td><td align="left">102 (6.8)</td><td align="left">3173 (1.6)</td></tr><tr><td align="left"/><td align="left">Other</td><td align="left">1137 (0.6)</td><td align="left">12 (0.8)</td><td align="left">1125 (0.6)</td></tr><tr><td align="left">Facility Geographic Region, <italic>n</italic> (%)</td><td align="left">Northeast</td><td align="left">40,705 (20.1)</td><td align="left">13 (0.9)</td><td align="left">40,692 (20.2)</td></tr><tr><td align="left"/><td align="left">Midwest</td><td align="left">62,268 (30.7)</td><td align="left">0 (0.0)</td><td align="left">62,268 (30.7)</td></tr><tr><td align="left"/><td align="left">South</td><td align="left">77,341 (38.1)</td><td align="left">390 (25.8)</td><td align="left">76,951 (38.2)</td></tr><tr><td align="left"/><td align="left">West</td><td align="left">22,621 (11.1)</td><td align="left">1110 (73.4)</td><td align="left">21,511 (10.7)</td></tr><tr><td align="left">Concomitant chemotherapy, <italic>n</italic> (%)</td><td align="left">No</td><td align="left">152,445 (75.1)</td><td align="left">1123 (74.2)</td><td align="left">151,322 (75.1)</td></tr><tr><td align="left"/><td align="left">Yes</td><td align="left">50,490 (24.9)</td><td align="left">390 (25.8)</td><td align="left">50,100 (24.9)</td></tr><tr><td align="left">Lymph node involvement, <italic>n</italic> (%)</td><td align="left">No</td><td align="left">159,083 (78.4)</td><td align="left">1188 (78.5)</td><td align="left">151,322 (78.4)</td></tr><tr><td align="left"/><td align="left">Yes</td><td align="left">43,852 (21.6)</td><td align="left">325 (21.5)</td><td align="left">43,527 (21.6)</td></tr><tr><td align="left">Comorbidity, <italic>n</italic> (%)</td><td align="left">0</td><td align="left">123,517 (60.9)</td><td align="left">1046 (69.1)</td><td align="left">122,471 (60.8)</td></tr><tr><td align="left"/><td align="left">1</td><td align="left">51,038 (25.1)</td><td align="left">317 (21.0)</td><td align="left">50,721 (25.2)</td></tr><tr><td align="left"/><td align="left">2 or more</td><td align="left">28,380 (14.0)</td><td align="left">150 (9.9)</td><td align="left">28,230 (14.0)</td></tr><tr><td align="left">Facility type (%)</td><td align="left">National Cancer Institute&#x02013;designated</td><td align="left">18,327 (9.0)</td><td align="left">169 (11.2)</td><td align="left">18,158 (9.0)</td></tr><tr><td align="left"/><td align="left">Comprehensive</td><td align="left">78,335 (38.6)</td><td align="left">582 (38.5)</td><td align="left">77,753 (38.6)</td></tr><tr><td align="left"/><td align="left">Teaching</td><td align="left">37,167 (18.3)</td><td align="left">179 (11.8)</td><td align="left">36,988 (18.4)</td></tr><tr><td align="left"/><td align="left">Other</td><td align="left">69,106 (34.1)</td><td align="left">583 (38.5)</td><td align="left">68,523 (34.0)</td></tr><tr><td align="left">Median income quintile, $ (%)</td><td align="left">&#x02009;&#x0003c;&#x02009;36,000</td><td align="left">36,016 (17.8)</td><td align="left">191 (12.8)</td><td align="left">35,825 (17.9)</td></tr><tr><td align="left"/><td align="left">36,000&#x02013;43,999</td><td align="left">43,300 (21.5)</td><td align="left">256 (17.2)</td><td align="left">43,044 (21.5)</td></tr><tr><td align="left"/><td align="left">44,000&#x02013;52,999</td><td align="left">43,239 (21.4)</td><td align="left">307 (20.6)</td><td align="left">42,932 (21.4)</td></tr><tr><td align="left"/><td align="left">53,000&#x02013;68,999</td><td align="left">43,968 (21.8)</td><td align="left">364 (24.4)</td><td align="left">43,604 (21.8)</td></tr><tr><td align="left"/><td align="left">&#x02009;&#x0003e;&#x02009;&#x02009;=&#x02009;69,000</td><td align="left">36,292 (17.5)</td><td align="left">372 (25.0)</td><td align="left">34,920 (17.4)</td></tr></tbody></table><table-wrap-foot><p><italic>Data Sources</italic>: Demographic data from the National Cancer Data Base (NCDB). Exposure data from Federal Emergency Management Agency (FEMA)</p><p>Other includes all Indigenous Populations on the Western hemisphere and the option &#x0201c;other&#x0201d;, which was provided to patients during data collection</p></table-wrap-foot></table-wrap><table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Mortality risk for patients exposed to a wildfire while receiving radiotherapy for stage III non-operable NSCLC, National Cancer Database (2004&#x02013;2019)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="4">Crude and adjusted estimates of hazard ratio</th></tr><tr><th align="left"/><th align="left">HR</th><th align="left">95% CI</th><th align="left"><italic>p</italic>-value</th></tr></thead><tbody><tr><td align="left">Crude</td><td char="." align="char">0.98</td><td char="&#x02013;" align="char">(0.96&#x02013;1.03)</td><td char="." align="char">0.08</td></tr><tr><td align="left">Adjusted</td><td char="." align="char">1.03</td><td char="." align="char">(1.00&#x02013;1.06)</td><td char="." align="char">0.02</td></tr></tbody></table></table-wrap></p><p id="Par15">Strengths of the study include the large national sample of patients diagnosed with NSCLC (over 70%) [<xref ref-type="bibr" rid="CR18">18</xref>], in all regions of the US, with detailed clinical and demographic information collected according to established cancer registry standards [<xref ref-type="bibr" rid="CR19">19</xref>]. Limitations include lack of information on date and reason for treatment breaks, disaster-related issues (e.g., displacement, worsening mental health, financial hardship), patient prognostic factors (smoking history, performance status), and inability to account for within-county variability in exposure to wildfire hazards as FEMA presidential disasters are declared at the county-level.</p><p id="Par16">The findings underscore the critical need for developing adaptation strategies within the healthcare sector, especially in oncology, to mitigate the adverse effects of climate-driven disasters on vulnerable patient populations [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. Future studies should evaluate whether characteristics of population subgroups known to be disproportionately impacted by worse health outcomes after NSCLC diagnosis modify the association between exposure to climate-driven disasters during cancer treatment and survival, as well as the potential of disaster recovery strategies aimed at modifiable factors such as altered radiation treatment schedule, post-disaster housing, mental health, diet, physical activity, and/or social support to alleviate the detrimental health consequences associated with exposure to climate-driven disasters.</p></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Katie E. Lichter and Bria Larson are co-first authors.</p></fn></fn-group><ack><p>The authors would like to thank the individuals and institutions whose support and contributions have facilitated this project. We thank tumor registrars for all their hard work with data collection, which makes studies such as this one possible. We also thank the Radiation Oncology Institute who awarded us grant funding for the project.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>K.L. jointly conceived the study with L.N. and O.M, edited the manuscript and supervised the analysis and submission; B.L. conducted the analysis under the supervision of L.N. and K.L. and prepared the manuscript; M.P. edited the manuscript; O.M. conceived of study jointly with L.N. and K.L.; L.N., directed study design, supervised the analysis and edited the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Grant funding was received from the Radiation Oncology Institute.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>Federal Emergency Management Agency (FEMA) data on presidential disaster declarations is publicly available at: <ext-link ext-link-type="uri" xlink:href="https://www.fema.gov/openfema-data-page/disaster-declarations-summaries-v2">https://www.fema.gov/openfema-data-page/disaster-declarations-summaries-v2</ext-link>. National Cancer Database (NCDB) data is available to researchers affiliated with Commission on Cancer accredited facilities in compliance with the Data Use Agreement: <ext-link ext-link-type="uri" xlink:href="https://www.facs.org/quality-programs/cancer-programs/national-cancer-database/puf/">https://www.facs.org/quality-programs/cancer-programs/national-cancer-database/puf/</ext-link></p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Competing interest</title><p id="Par17">The authors declare no competing interests.</p></notes><notes id="FPar2"><title>Ethical approval</title><p id="Par18">The institutional review board of the Morehouse School of Medicine granted an exemption for this study in accordance with 45 CFR &#x000a7;46.102(f).</p></notes><notes id="FPar3"><title>Consent to participate</title><p id="Par19">The study used de-identified data and therefore was deemed exempt from informed consent.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Abatzoglou</surname><given-names>JT</given-names></name><name><surname>Williams</surname><given-names>AP</given-names></name></person-group><article-title>Impact of anthropogenic climate change on wildfire across western US forests</article-title><source>Proc Natl Acad Sci USA</source><year>2016</year><volume>113</volume><fpage>11770</fpage><lpage>11775</lpage><pub-id pub-id-type="doi">10.1073/pnas.1607171113</pub-id><pub-id pub-id-type="pmid">27791053</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Abatzoglou JT, Williams AP (2016) Impact of anthropogenic climate change on wildfire across western US forests. Proc Natl Acad Sci USA 113:11770&#x02013;11775<pub-id pub-id-type="pmid">27791053</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Schoennagel</surname><given-names>T</given-names></name><name><surname>Balch</surname><given-names>JK</given-names></name><name><surname>Brenkert-Smith</surname><given-names>H</given-names></name><etal/></person-group><article-title>Adapt to more wildfire in western North American forests as climate changes</article-title><source>Proc Natl Acad Sci USA</source><year>2017</year><volume>114</volume><fpage>4582</fpage><lpage>4590</lpage><pub-id pub-id-type="doi">10.1073/pnas.1617464114</pub-id><pub-id pub-id-type="pmid">28416662</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Schoennagel T, Balch JK, Brenkert-Smith H et al (2017) Adapt to more wildfire in western North American forests as climate changes. Proc Natl Acad Sci USA 114:4582&#x02013;4590<pub-id pub-id-type="pmid">28416662</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>AP</given-names></name><name><surname>Abatzoglou</surname><given-names>JT</given-names></name><name><surname>Gershunov</surname><given-names>A</given-names></name><etal/></person-group><article-title>Observed impacts of anthropogenic climate change on wildfire in california</article-title><source>Earth&#x02019;s Future</source><year>2019</year><volume>7</volume><fpage>892</fpage><lpage>910</lpage><pub-id pub-id-type="doi">10.1029/2019EF001210</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Williams AP, Abatzoglou JT, Gershunov A et al (2019) Observed impacts of anthropogenic climate change on wildfire in california. Earth&#x02019;s Future 7:892&#x02013;910</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Nogueira</surname><given-names>LM</given-names></name><name><surname>Yabroff</surname><given-names>KR</given-names></name><name><surname>Bernstein</surname><given-names>A</given-names></name></person-group><article-title>Climate change and cancer</article-title><source>CA Cancer J Clin</source><year>2020</year><volume>70</volume><fpage>239</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.3322/caac.21610</pub-id><pub-id pub-id-type="pmid">32420634</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Nogueira LM, Yabroff KR, Bernstein A (2020) Climate change and cancer. CA Cancer J Clin 70:239&#x02013;244<pub-id pub-id-type="pmid">32420634</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Nogueira</surname><given-names>LM</given-names></name><name><surname>Crane</surname><given-names>TE</given-names></name><name><surname>Ortiz</surname><given-names>AP</given-names></name><name><surname>D&#x02019;Angelo</surname><given-names>H</given-names></name><name><surname>Neta</surname><given-names>G</given-names></name></person-group><article-title>Climate change and cancer</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2023</year><volume>32</volume><fpage>869</fpage><lpage>875</lpage><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-22-1234</pub-id><pub-id pub-id-type="pmid">37184574</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Nogueira LM, Crane TE, Ortiz AP, D&#x02019;Angelo H, Neta G (2023) Climate change and cancer. Cancer Epidemiol Biomarkers Prev 32:869&#x02013;875<pub-id pub-id-type="pmid">37184574</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Lichter</surname><given-names>KE</given-names></name><name><surname>Baniel</surname><given-names>CC</given-names></name><name><surname>Do</surname><given-names>I</given-names></name><etal/></person-group><article-title>Effects of wildfire events on California radiation oncology clinics and patients</article-title><source>Adv Radiat Oncol</source><year>2024</year><volume>9</volume><fpage>101395</fpage><pub-id pub-id-type="doi">10.1016/j.adro.2023.101395</pub-id><pub-id pub-id-type="pmid">38304108</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Lichter KE, Baniel CC, Do I et al (2024) Effects of wildfire events on California radiation oncology clinics and patients. Adv Radiat Oncol 9:101395<pub-id pub-id-type="pmid">38304108</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Roach</surname><given-names>MC</given-names></name><name><surname>Robinson</surname><given-names>CG</given-names></name><name><surname>Bradley</surname><given-names>JD</given-names></name></person-group><article-title>Natural disasters and the importance of minimizing subsequent radiation therapy interruptions for locally advanced lung cancer</article-title><source>Int J Radiat Oncol Biol Phys</source><year>2018</year><volume>100</volume><fpage>836</fpage><lpage>837</lpage><pub-id pub-id-type="doi">10.1016/j.ijrobp.2017.11.001</pub-id><pub-id pub-id-type="pmid">29485056</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Roach MC, Robinson CG, Bradley JD (2018) Natural disasters and the importance of minimizing subsequent radiation therapy interruptions for locally advanced lung cancer. Int J Radiat Oncol Biol Phys 100:836&#x02013;837<pub-id pub-id-type="pmid">29485056</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">National Comprehensive Cancer Network. (2024) NCCN Clinical Practice Guidelines in Oncology. <ext-link ext-link-type="uri" xlink:href="https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf">https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf</ext-link></mixed-citation></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Bray</surname><given-names>F</given-names></name><name><surname>Laversanne</surname><given-names>M</given-names></name><name><surname>Sung</surname><given-names>H</given-names></name><etal/></person-group><article-title>Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title><source>Cancer J Clin</source><year>2024</year><volume>74</volume><fpage>229</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.3322/caac.21834</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 74:229&#x02013;263</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Siegel</surname><given-names>RL</given-names></name><name><surname>Giaquinto</surname><given-names>AN</given-names></name><name><surname>Jemal</surname><given-names>A</given-names></name></person-group><article-title>Cancer statistics, 2024</article-title><source>CA Cancer J Clin</source><year>2024</year><volume>74</volume><fpage>12</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.3322/caac.21820</pub-id><pub-id pub-id-type="pmid">38230766</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. CA Cancer J Clin 74:12&#x02013;49<pub-id pub-id-type="pmid">38230766</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="book"><person-group person-group-type="author"><name><surname>Araujo</surname><given-names>LH</given-names></name><name><surname>Horn</surname><given-names>L</given-names></name><name><surname>Merritt</surname><given-names>RE</given-names></name><name><surname>Shilo</surname><given-names>K</given-names></name><name><surname>Xu-Welliver</surname><given-names>M</given-names></name><name><surname>Carbone</surname><given-names>DP</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Niederhuber</surname><given-names>JE</given-names></name><name><surname>Armitage</surname><given-names>JO</given-names></name><name><surname>Kastan</surname><given-names>MB</given-names></name><name><surname>Doroshow</surname><given-names>JH</given-names></name><name><surname>Tepper</surname><given-names>JE</given-names></name></person-group><article-title>Cancer of the lung: non-small cell lung cancer and small cell lung cancer</article-title><source>Abeloff&#x02019;s clinical oncology</source><year>2020</year><edition>6</edition><publisher-loc>Philadelphia</publisher-loc><publisher-name>Elsevier</publisher-name><fpage>1108</fpage><lpage>58.e16</lpage></element-citation><mixed-citation id="mc-CR11" publication-type="book">Araujo LH, Horn L, Merritt RE, Shilo K, Xu-Welliver M, Carbone DP (2020) Cancer of the lung: non-small cell lung cancer and small cell lung cancer. In: Niederhuber JE, Armitage JO, Kastan MB, Doroshow JH, Tepper JE (eds) Abeloff&#x02019;s clinical oncology, 6th edn. Elsevier, Philadelphia, pp 1108&#x02013;58.e16</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Jiang</surname><given-names>GL</given-names></name><name><surname>Fu</surname><given-names>XL</given-names></name><etal/></person-group><article-title>The impact of overall treatment time on outcomes in radiation therapy for non-small cell lung cancer</article-title><source>Lung Cancer</source><year>2000</year><volume>28</volume><fpage>11</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/S0169-5002(99)00113-0</pub-id><pub-id pub-id-type="pmid">10704704</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Chen M, Jiang GL, Fu XL et al (2000) The impact of overall treatment time on outcomes in radiation therapy for non-small cell lung cancer. Lung Cancer 28:11&#x02013;19<pub-id pub-id-type="pmid">10704704</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Koukourakis</surname><given-names>M</given-names></name><name><surname>Hlouverakis</surname><given-names>G</given-names></name><name><surname>Kosma</surname><given-names>L</given-names></name><etal/></person-group><article-title>The impact of overall treatment time on the results of radiotherapy for nonsmall cell lung carcinoma</article-title><source>Int J Radiat Oncol Biol Phys</source><year>1996</year><volume>34</volume><fpage>315</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1016/0360-3016(95)02102-7</pub-id><pub-id pub-id-type="pmid">8567332</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Koukourakis M, Hlouverakis G, Kosma L et al (1996) The impact of overall treatment time on the results of radiotherapy for nonsmall cell lung carcinoma. Int J Radiat Oncol Biol Phys 34:315&#x02013;322<pub-id pub-id-type="pmid">8567332</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Machtay</surname><given-names>M</given-names></name><name><surname>Hsu</surname><given-names>C</given-names></name><name><surname>Komaki</surname><given-names>R</given-names></name><etal/></person-group><article-title>Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Oncology Group (RTOG) experience</article-title><source>Int J Radiat Oncol Biol Phys</source><year>2005</year><volume>63</volume><fpage>667</fpage><lpage>671</lpage><pub-id pub-id-type="doi">10.1016/j.ijrobp.2005.03.037</pub-id><pub-id pub-id-type="pmid">15927409</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Machtay M, Hsu C, Komaki R et al (2005) Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Oncology Group (RTOG) experience. Int J Radiat Oncol Biol Phys 63:667&#x02013;671<pub-id pub-id-type="pmid">15927409</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>McMillan</surname><given-names>MT</given-names></name><name><surname>Ojerholm</surname><given-names>E</given-names></name><name><surname>Verma</surname><given-names>V</given-names></name><etal/></person-group><article-title>Radiation treatment time and overall survival in locally advanced non-small cell lung cancer</article-title><source>Int J Radiat Oncol Biol Phys</source><year>2017</year><volume>98</volume><fpage>1142</fpage><lpage>1152</lpage><pub-id pub-id-type="doi">10.1016/j.ijrobp.2017.04.004</pub-id><pub-id pub-id-type="pmid">28721898</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">McMillan MT, Ojerholm E, Verma V et al (2017) Radiation treatment time and overall survival in locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys 98:1142&#x02013;1152<pub-id pub-id-type="pmid">28721898</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Nogueira</surname><given-names>LM</given-names></name><name><surname>Sahar</surname><given-names>L</given-names></name><name><surname>Efstathiou</surname><given-names>JA</given-names></name><name><surname>Jemal</surname><given-names>A</given-names></name><name><surname>Yabroff</surname><given-names>KR</given-names></name></person-group><article-title>Association between declared hurricane disasters and survival of patients with lung cancer undergoing radiation treatment</article-title><source>JAMA</source><year>2019</year><volume>322</volume><fpage>269</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.1001/jama.2019.7657</pub-id><pub-id pub-id-type="pmid">31310288</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Nogueira LM, Sahar L, Efstathiou JA, Jemal A, Yabroff KR (2019) Association between declared hurricane disasters and survival of patients with lung cancer undergoing radiation treatment. JAMA 322:269&#x02013;271<pub-id pub-id-type="pmid">31310288</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Espinel</surname><given-names>Z</given-names></name><name><surname>Shultz</surname><given-names>JM</given-names></name><name><surname>Aubry</surname><given-names>VP</given-names></name><etal/></person-group><article-title>Protecting vulnerable patient populations from climate hazards: the role of the nation&#x02019;s cancer centers</article-title><source>J Natl Cancer Inst</source><year>2023</year><volume>115</volume><fpage>1252</fpage><lpage>1261</lpage><pub-id pub-id-type="doi">10.1093/jnci/djad139</pub-id><pub-id pub-id-type="pmid">37490548</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Espinel Z, Shultz JM, Aubry VP et al (2023) Protecting vulnerable patient populations from climate hazards: the role of the nation&#x02019;s cancer centers. J Natl Cancer Inst 115:1252&#x02013;1261<pub-id pub-id-type="pmid">37490548</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Mallin</surname><given-names>K</given-names></name><name><surname>Browner</surname><given-names>A</given-names></name><name><surname>Palis</surname><given-names>B</given-names></name><etal/></person-group><article-title>Incident cases captured in the national cancer database compared with those in U.S. population based central cancer registries in 2012&#x02013;2014</article-title><source>Ann Surg Oncol</source><year>2019</year><volume>26</volume><fpage>1604</fpage><lpage>1612</lpage><pub-id pub-id-type="doi">10.1245/s10434-019-07213-1</pub-id><pub-id pub-id-type="pmid">30737668</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Mallin K, Browner A, Palis B et al (2019) Incident cases captured in the national cancer database compared with those in U.S. population based central cancer registries in 2012&#x02013;2014. Ann Surg Oncol 26:1604&#x02013;1612<pub-id pub-id-type="pmid">30737668</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Palis</surname><given-names>BE</given-names></name><name><surname>Janczewski</surname><given-names>LM</given-names></name><name><surname>Browner</surname><given-names>AE</given-names></name><etal/></person-group><article-title>The national cancer database conforms to the standardized framework for registry and data quality</article-title><source>Ann Surg Oncol</source><year>2024</year><volume>31</volume><fpage>5546</fpage><lpage>5559</lpage><pub-id pub-id-type="doi">10.1245/s10434-024-15393-8</pub-id><pub-id pub-id-type="pmid">38717542</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Palis BE, Janczewski LM, Browner AE et al (2024) The national cancer database conforms to the standardized framework for registry and data quality. Ann Surg Oncol 31:5546&#x02013;5559<pub-id pub-id-type="pmid">38717542</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="other">World Health Organization. (2020) International classification of diseases for oncology. <ext-link ext-link-type="uri" xlink:href="https://iris.who.int/bitstream/handle/10665/96612/9789241548496_eng.pdf">https://iris.who.int/bitstream/handle/10665/96612/9789241548496_eng.pdf</ext-link></mixed-citation></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Aup&#x000e9;rin</surname><given-names>A</given-names></name><name><surname>Le P&#x000e9;choux</surname><given-names>C</given-names></name><name><surname>Rolland</surname><given-names>E</given-names></name><etal/></person-group><article-title>Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer</article-title><source>J Clin Oncol</source><year>2010</year><volume>28</volume><fpage>2181</fpage><lpage>2190</lpage><pub-id pub-id-type="doi">10.1200/JCO.2009.26.2543</pub-id><pub-id pub-id-type="pmid">20351327</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Aup&#x000e9;rin A, Le P&#x000e9;choux C, Rolland E et al (2010) Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol 28:2181&#x02013;2190<pub-id pub-id-type="pmid">20351327</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Xi</surname><given-names>Y</given-names></name><name><surname>Boffa</surname><given-names>DJ</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Nogueira</surname><given-names>LM</given-names></name></person-group><article-title>Association of wildfire exposure while recovering from lung cancer surgery with overall survival</article-title><source>JAMA Oncol</source><year>2023</year><volume>9</volume><fpage>1214</fpage><lpage>1220</lpage><pub-id pub-id-type="doi">10.1001/jamaoncol.2023.2144</pub-id><pub-id pub-id-type="pmid">37498574</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Zhang D, Xi Y, Boffa DJ, Liu Y, Nogueira LM (2023) Association of wildfire exposure while recovering from lung cancer surgery with overall survival. JAMA Oncol 9:1214&#x02013;1220<pub-id pub-id-type="pmid">37498574</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="other">U.S. Census Bureau (2023) Geographic levels: regions and divisions. <ext-link ext-link-type="uri" xlink:href="https://www.census.gov/programs-surveys/economic-census/guidance-geographies/levels.html#par_textimage_34">https://www.census.gov/programs-surveys/economic-census/guidance-geographies/levels.html#par_textimage_34</ext-link></mixed-citation></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Klabunde</surname><given-names>CN</given-names></name><name><surname>Potosky</surname><given-names>AL</given-names></name><name><surname>Legler</surname><given-names>JM</given-names></name><name><surname>Warren</surname><given-names>JL</given-names></name></person-group><article-title>Development of a comorbidity index using physician claims data</article-title><source>J Clin Epidemiol</source><year>2000</year><volume>53</volume><fpage>1258</fpage><lpage>1267</lpage><pub-id pub-id-type="doi">10.1016/S0895-4356(00)00256-0</pub-id><pub-id pub-id-type="pmid">11146273</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Klabunde CN, Potosky AL, Legler JM, Warren JL (2000) Development of a comorbidity index using physician claims data. J Clin Epidemiol 53:1258&#x02013;1267<pub-id pub-id-type="pmid">11146273</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Hern&#x000e1;n</surname><given-names>MA</given-names></name><name><surname>Hern&#x000e1;ndez-D&#x000ed;az</surname><given-names>S</given-names></name><name><surname>Werler</surname><given-names>MM</given-names></name><name><surname>Mitchell</surname><given-names>AA</given-names></name></person-group><article-title>Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology</article-title><source>Am J Epidemiol</source><year>2002</year><volume>155</volume><fpage>176</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1093/aje/155.2.176</pub-id><pub-id pub-id-type="pmid">11790682</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Hern&#x000e1;n MA, Hern&#x000e1;ndez-D&#x000ed;az S, Werler MM, Mitchell AA (2002) Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol 155:176&#x02013;184<pub-id pub-id-type="pmid">11790682</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Yabroff</surname><given-names>KR</given-names></name><name><surname>Boehm</surname><given-names>AL</given-names></name><name><surname>Nogueira</surname><given-names>LM</given-names></name><etal/></person-group><article-title>An essential goal within reach: attaining diversity, equity, and inclusion for the Journal of the National Cancer Institute journals</article-title><source>J Natl Cancer Inst</source><year>2023</year><volume>115</volume><fpage>1115</fpage><lpage>1120</lpage><pub-id pub-id-type="doi">10.1093/jnci/djad177</pub-id><pub-id pub-id-type="pmid">37806780</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Yabroff KR, Boehm AL, Nogueira LM et al (2023) An essential goal within reach: attaining diversity, equity, and inclusion for the Journal of the National Cancer Institute journals. J Natl Cancer Inst 115:1115&#x02013;1120<pub-id pub-id-type="pmid">37806780</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Gay</surname><given-names>HA</given-names></name><name><surname>Santiago</surname><given-names>R</given-names></name><name><surname>Gil</surname><given-names>B</given-names></name><etal/></person-group><article-title>Lessons learned from Hurricane Maria in Puerto Rico: practical measures to mitigate the impact of a catastrophic natural disaster on radiation oncology patients</article-title><source>Pract Radiat Oncol</source><year>2019</year><volume>9</volume><fpage>305</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1016/j.prro.2019.03.007</pub-id><pub-id pub-id-type="pmid">30999000</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Gay HA, Santiago R, Gil B et al (2019) Lessons learned from Hurricane Maria in Puerto Rico: practical measures to mitigate the impact of a catastrophic natural disaster on radiation oncology patients. Pract Radiat Oncol 9:305&#x02013;321<pub-id pub-id-type="pmid">30999000</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Taparra</surname><given-names>K</given-names></name><name><surname>Purdy</surname><given-names>M</given-names></name><name><surname>Raphael</surname><given-names>KL</given-names></name></person-group><article-title>From ashes to action&#x02014;indigenous health perspectives on the L&#x00101;hain&#x00101; fires</article-title><source>N Engl J Med</source><year>2023</year><volume>389</volume><fpage>1543</fpage><lpage>1546</lpage><pub-id pub-id-type="doi">10.1056/NEJMp2309966</pub-id><pub-id pub-id-type="pmid">37733295</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Taparra K, Purdy M, Raphael KL (2023) From ashes to action&#x02014;indigenous health perspectives on the L&#x00101;hain&#x00101; fires. N Engl J Med 389:1543&#x02013;1546<pub-id pub-id-type="pmid">37733295</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Shultz</surname><given-names>JM</given-names></name><name><surname>Galea</surname><given-names>S</given-names></name><name><surname>Espinel</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Safeguarding medically high-risk patients from compounding disasters</article-title><source>Lancet Reg Health Am</source><year>2024</year><volume>32</volume><fpage>100714</fpage><pub-id pub-id-type="pmid">38510788</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Shultz JM, Galea S, Espinel Z et al (2024) Safeguarding medically high-risk patients from compounding disasters. Lancet Reg Health Am 32:100714<pub-id pub-id-type="pmid">38510788</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>